
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Cancer Epidemiology Biomarkers & Prevention, Vol 7, Issue 7 559-565, Copyright © 1998 by American Association for Cancer Research
ARTICLES |
AA Evans, AP O'Connell, JC Pugh, WS Mason, FM Shen, GC Chen, WY Lin, A Dia, S M'Boup, B Drame and WT London
Division of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. A_Evans@fccc.edu
The risk of hepatocellular carcinoma (HCC) varies significantly among hepatitis B virus (HBV) carriers from different geographic regions. We compared serological markers of HBV infection in adult male carriers from Haimen City, China and Senegal, West Africa, where the prevalence of chronic infection is similar. HCC mortality among HBV carriers is much higher in Haimen City than it is in Senegal (age-standardized rate, 878 versus 68 per l0(5) person-years). A dramatic difference was observed when HBV DNA levels in serum were assessed among carriers by Southern blot. In the Senegalese group (n = 289), 14.5% were HBV DNA positive by Southern blot in their 20s, and this percentage declined in each subsequent decade of age to 3.3, 2.9, and 0% thereafter. In the Chinese group (n = 285), a higher prevalence of HBV DNA positivity and a less consistent reduction were seen; 29.4% were positive in their 20s, and 30.2, 23.6, and 20.6%, respectively, were positive in each subsequent decade of age. Among 102 male Asian-American HBV carriers, the prevalence of HBV DNA positivity was intermediate between the Chinese and Senegalese populations (36.8, 10.7, 3.0, and 4.6% in each subsequent decade of age). Viral titers were similar among those who were HBV DNA positive in all three populations [median value, 10(7) virions/ml (range, 10(6)-10(9) virions/ml)]. The presence of HBV DNA in serum was positively associated with serum glutathione S-transferase, a marker of liver damage. These findings suggest that the more prolonged maintenance of productive virus infection in the Chinese carriers compared with the Senegalese carriers may explain their higher risk of HCC. This profound difference in the natural history of chronic infection may be due to earlier age of infection in China or to as yet unknown environmental or genetic factors.
This article has been cited by other articles:
![]() |
G. D. Kirk, E. Bah, and R. Montesano Molecular epidemiology of human liver cancer: insights into etiology, pathogenesis and prevention from The Gambia, West Africa Carcinogenesis, October 1, 2006; 27(10): 2070 - 2082. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Schottenfeld and J. Beebe-Dimmer Chronic inflammation: a common and important factor in the pathogenesis of neoplasia. CA Cancer J Clin, March 1, 2006; 56(2): 69 - 83. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-W. Yu, S.-H. Yeh, P.-J. Chen, Y.-F. Liaw, C.-L. Lin, C.-J. Liu, W.-L. Shih, J.-H. Kao, D.-S. Chen, and C.-J. Chen Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men J Natl Cancer Inst, February 16, 2005; 97(4): 265 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Q. Konnick, M. Erali, E. R. Ashwood, and D. R. Hillyard Evaluation of the COBAS Amplicor HBV Monitor Assay and Comparison with the Ultrasensitive HBV Hybrid Capture 2 Assay for Quantification of Hepatitis B Virus DNA J. Clin. Microbiol., February 1, 2005; 43(2): 596 - 603. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F. Steel, M. G. Trotter, P. B. Nakajima, T. S. Mattu, G. Gonye, and T. Block Efficient and Specific Removal of Albumin from Human Serum Samples Mol. Cell. Proteomics, April 1, 2003; 2(4): 262 - 270. [Abstract] [Full Text] [PDF] |
||||
![]() |
F.-M. Suk, M.-H. Lin, M. Newman, S. Pan, S.-H. Chen, J.-D. Liu, and C. Shih Replication Advantage and Host Factor-Independent Phenotypes Attributable to a Common Naturally Occurring Capsid Mutation (I97L) in Human Hepatitis B Virus J. Virol., October 25, 2002; 76(23): 12069 - 12077. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Cainelli and S. Vento Sequelae and Serologic Outcome in Persons with Hepatitis B Virus Infection Ann Intern Med, October 1, 2002; 137(7): 619 - 619. [Full Text] [PDF] |
||||
![]() |
C. Seeger and W. S. Mason Hepatitis B Virus Biology Microbiol. Mol. Biol. Rev., March 1, 2000; 64(1): 51 - 68. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |